Cancer immunotherapy with mRNA-transfected dendritic cells.
about
A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma.Dendritic cell-based cancer immunotherapy for colorectal cancerRNA-Based Vaccines in Cancer ImmunotherapyHarnessing immunosurveillance: current developments and future directions in cancer immunotherapyIntradermal electroporation of naked replicon RNA elicits strong immune responsesTheranostic mRNA-loaded microbubbles in the lymphatics of dogs: implications for drug delivery.Electroporation advances in large animals.Quantitative effect of suboptimal codon usage on translational efficiency of mRNA encoding HIV-1 gag in intact T cells.Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapyMaturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses.Protein transduction from retroviral Gag precursorsAndrogen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice.Dendritic cell-based human immunodeficiency virus vaccine.The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection.Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer.Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.Medical biofilms.Three-Dimensional Mapping of mRNA Export through the Nuclear Pore Complex.Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma.Current immunotherapeutic approaches in pancreatic cancer.Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted NefAntigenic targets for renal cell carcinoma immunotherapy.Nucleofection induces transient eIF2α phosphorylation by GCN2 and PERK.Antisense therapy for restenosis following percutaneous coronary intervention.Multifunctional triblock copolymers for intracellular messenger RNA deliveryAdhesion to substrates induces dendritic cell endothelization and decreases immunological response.Enhancement of dendritic cells as vaccines for cancerAntigen-specific cellular immunotherapy of leukemia.Dendritic cells: tools and targets for antitumor vaccination.Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureusEfficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individualsImmunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial.What is recent in pancreatic cancer immunotherapy?Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.Dendritic cell vaccine strategies for renal cell carcinoma.Harnessing the immune system to treat cancer.DC-based cancer vaccines.CD34-derived dendritic cells transfected ex vivo with HIV-Gag mRNA induce polyfunctional T-cell responses in nonhuman primates.
P2860
Q24814644-2A1A089E-8A22-4BAF-B318-6A426996F12DQ26751339-AC0957D1-D4D4-40CC-B29A-618B52115ADDQ26776028-B195DA3A-7716-4831-9316-A2F9442CA0A7Q27021570-CD03840F-2317-4499-8C18-5C742536497AQ27310340-7E04F576-082E-4A93-B690-CC2CD5FD8F99Q30422136-4CF82FE2-1EED-4A53-862A-F2A59A3C5037Q30476834-C42DF0F8-A16F-4469-902E-6E7C144CA7FAQ33340267-875EDC05-914D-4C12-8234-55D975699BEDQ33637584-2BCDF427-CEAD-4ADD-995A-D663F06A7D55Q33786246-7605B589-EA4E-40DF-A337-192608A6B981Q33842785-546CF43F-0D62-4E7B-968A-E17D9CE23EF9Q33872776-C8C3E9FE-5727-4F49-9301-51B4E2CFD5A1Q33874652-CE90B53C-772B-4860-A570-7B4DC322BB46Q33924531-244CB466-9753-4E37-A1F1-A2251DFBB8EAQ34071375-37F4F753-D329-48B6-8CC1-285FB63F8EDCQ34231139-62EBCC15-256A-4CE4-BBD9-5EE65036CE08Q34353635-3D55D5C0-58FD-49D6-948F-C5B92C76112DQ34612545-061E7B53-3DAF-4539-A4CF-4210C76C2A98Q34764576-CE763E92-67F7-49D8-BCA8-54D1D163DCD5Q34774750-EDFD7E2D-0B76-45D5-B359-1134A3798EAEQ35039430-8D760FEC-8270-417A-A9F4-D287430738B1Q35212837-9CAF84FD-FB36-491B-A871-2558EC08CE9CQ35849445-12284448-73A9-48D4-AA62-3C6409AE55C9Q35925619-B2DA1714-F0FE-4945-A573-7750CC92B902Q35936953-B70DDAF6-D655-45D8-ADDD-9834B363B0AFQ36040825-D95DAE7D-F2DF-4100-BF98-360B2B3B476DQ36140780-B9E0E313-358A-4367-8C2E-60E89433D032Q36146867-3119FA31-33A7-405A-B32E-617C981B16ADQ36209210-657F2839-67F4-40E4-9D54-BF8FD9F70405Q36240201-573A72CB-7307-4274-8C83-B5E100C9BCA8Q36284556-25F97C4C-30DB-4426-A8FA-FAF801C8831AQ36380959-DC6DFD9A-2E29-4A5C-BC4E-7D9C2F0A5618Q36498151-CFCD9E59-5612-4175-BA49-C666F2E588B8Q36576603-BA084087-6DE2-4B1B-811C-630E22512BB7Q36665335-25130291-373C-4BBD-A201-ED154D12EA74Q36689038-83D16990-82E1-49B3-B297-6FF1276AC0F7Q36717351-EDB5A211-8EF7-4887-BC56-E0A677F23857Q36809755-ED5E148B-D351-46CA-A2E8-D3E05751A304Q36809780-7A8D38FD-9FA7-41FB-AC05-636098BC8B24Q36830663-071C9743-F4ED-43D6-A11F-1E1DB3201F11
P2860
Cancer immunotherapy with mRNA-transfected dendritic cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cancer immunotherapy with mRNA-transfected dendritic cells.
@ast
Cancer immunotherapy with mRNA-transfected dendritic cells.
@en
type
label
Cancer immunotherapy with mRNA-transfected dendritic cells.
@ast
Cancer immunotherapy with mRNA-transfected dendritic cells.
@en
prefLabel
Cancer immunotherapy with mRNA-transfected dendritic cells.
@ast
Cancer immunotherapy with mRNA-transfected dendritic cells.
@en
P2860
P1476
Cancer immunotherapy with mRNA-transfected dendritic cells.
@en
P2093
Eli Gilboa
Johannes Vieweg
P2860
P304
P356
10.1111/J.0105-2896.2004.00139.X
P577
2004-06-01T00:00:00Z